Patents
More topics under "C07D - Heterocyclic compounds" (1,537,440)
C07D 201 - Preparation, separation, purification, or stabilisation of unsubstituted lactams (2,192)
C07D 203 - Heterocyclic compounds containing three-membered rings with one nitrogen atom as the only ring hetero atom (1,097)
C07D 205 - Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom (6,868)
C07D 207 - Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom (40,304)
C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
C07D 217 - Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems (11,865)
C07D 219 - Heterocyclic compounds containing acridine or hydrogenated acridine ring systems (2,120)
C07D 221 - Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups (10,931)
C07D 223 - Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom (8,732)
C07D 225 - Heterocyclic compounds containing rings of more than seven members having one nitrogen atom as the only ring hetero atom (1,649)
C07D 227 - Heterocyclic compounds containing rings having one nitrogen atom as the only ring hetero atom, according to more than one of groups (473)
C07D 229 - Heterocyclic compounds containing rings of less than five members having two nitrogen atoms as the only ring hetero atoms (515)
C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
C07D 237 - Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings (8,468)
C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673)
C07D 243 - Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms (5,961)
C07D 245 - Heterocyclic compounds containing rings of more than seven members having two nitrogen atoms as the only ring hetero atoms (898)
C07D 247 - Heterocyclic compounds containing rings having two nitrogen atoms as the only ring hetero atoms, according to more than one of groups (239)
C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
C07D 251 - Heterocyclic compounds containing 1,3,5-triazine rings (10,913)
C07D 253 - Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group (2,967)
C07D 255 - Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups (739)
C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612)
C07D 259 - Heterocyclic compounds containing rings having more than four nitrogen atoms as the only ring hetero atoms (488)
C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459)
C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
C07D 267 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms (2,022)
C07D 269 - Heterocyclic compounds containing rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms according to more than one of groups (111)
C07D 271 - Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms (7,144)
C07D 273 - Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups (2,368)
C07D 275 - Heterocyclic compounds containing 1, 2-thiazole or hydrogenated 1,2-thiazole rings (4,972)
C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621)
C07D 279 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms (5,149)
C07D 281 - Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one sulfur atom as the only ring hetero atoms (1,924)
C07D 283 - Heterocyclic compounds containing rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms, according to more than one of groups (102)
C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964)
C07D 291 - Heterocyclic compounds containing rings having nitrogen, oxygen and sulfur atoms as the only ring hetero atoms (1,087)
C07D 293 - Heterocyclic compounds containing rings having nitrogen and selenium or nitrogen and tellurium, with or without oxygen or sulfur atoms, as the ring hetero atoms (553)
C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
C07D 301 - Preparation of oxiranes (10,136)
C07D 303 - Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom (12,512)
C07D 305 - Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms (5,442)
C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815)
C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
C07D 313 - Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom (3,580)
C07D 315 - Heterocyclic compounds containing rings having one oxygen atom as the only ring hetero atom according to more than one of groups (1,360)
C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
C07D 321 - Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups (2,079)
C07D 323 - Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms (1,581)
C07D 325 - Heterocyclic compounds containing rings having oxygen as the only ring hetero atom according to more than one of groups (168)
C07D 327 - Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms (2,428)
C07D 329 - Heterocyclic compounds containing rings having oxygen and selenium or oxygen and tellurium atoms as the only ring hetero atoms (47)
C07D 331 - Heterocyclic compounds containing rings of less than five members, having one sulfur atom as the only ring hetero atom (456)
C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883)
C07D 335 - Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom (4,725)
C07D 337 - Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom (875)
C07D 339 - Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms (3,352)
C07D 341 - Heterocyclic compounds containing rings having three or more sulfur atoms as the only ring hetero atoms (281)
C07D 343 - Heterocyclic compounds containing rings having sulfur and selenium or sulfur and tellurium atoms as the only ring hetero atoms (52)
C07D 345 - Heterocyclic compounds containing rings having selenium or tellurium atoms as the only ring hetero atoms (419)
C07D 347 - Heterocyclic compounds containing rings having halogen atoms as ring hetero atoms (38)
C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
C07D 407 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group (11,963)
C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
C07D 411 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms (2,465)
C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
C07D 415 - Heterocyclic compounds containing the thiamine skeleton (90)
C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
C07D 419 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms (1,431)
C07D 421 - Heterocyclic compounds containing two or more hetero rings, at least one ring having selenium, tellurium, or halogen atoms as ring hetero atoms (480)
C07D 451 - Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.02,4] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof (5,273)
C07D 453 - Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids (5,704)
C07D 455 - Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine (2,122)
C07D 457 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid (836)
C07D 459 - Heterocyclic compounds containing benz [g] indolo [2, 3-a] quinolizine ring systems, e.g. yohimbine; 16, 18-lactones thereof, e.g. reserpic acid lactone (97)
C07D 461 - Heterocyclic compounds containing indolo [3, 2, 1-d, e] pyrido [3, 2, 1-i, j] [1, 5]-naphthyridine ring systems, e.g. vincamine (286)
C07D 463 - Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (613)
C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
C07D 475 - Heterocyclic compounds containing pteridine ring systems (2,718)
C07D 477 - Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (2,484)
C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
C07D 489 - Heterocyclic compounds containing 4ah-8, 9 c- iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: (2,334)
C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336)
C07D 497 - Heterocyclic compounds containing in the condensed system at least one hetero ring having oxygen and sulfur atoms as the only ring hetero atoms (1,069)
C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
C07D 499 - Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (3,448)
C07D 501 - Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (7,574)
C07D 503 - Heterocyclic compounds containing 4-oxa-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxapenicillins, clavulanic acid derivatives; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (648)
C07D 505 - Heterocyclic compounds containing 5-oxa-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula: , e.g. oxacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring (556)
C07D 507 - Heterocyclic compounds containing a condensed beta-lactam ring system, not provided for by groups , or; Such ring systems being further condensed (161)
C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
C07D 515 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (877)
C07D 517 - Heterocyclic compounds containing in the condensed system at least one hetero ring having selenium, tellurium, or halogen atoms as ring hetero atoms (452)
C07D 519 - Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups or (11,041)
C07D 521 - Heterocyclic compounds containing unspecified hetero rings (16,203)
Patents for C07D - Heterocyclic compounds (10,420)
05/1984
05/01/1984US4446137 Cephalosporin derivative and pharmaceutical composition containing the derivative
04/1984
04/18/1984EP0105459A2 Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them
04/12/1984WO1984001382A1 Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method
04/03/1984CA1164871A1 Isoxazolylbenzamides
04/03/1984CA1164860A1 Cephalosporins, processes for their preparation and pharmaceutical compositions containing them
03/1984
03/27/1984US4439363 Acetylmethyl ester of hetacyllin and/or salts of this ester
03/21/1984EP0103264A2 New cephem compounds and processes for preparation thereof
03/14/1984EP0102896A1 Crystalline forms of addition salts with acids, of ((amino-2-thiazolyl-4)-2-methoxyimino-2-acetamido)-7-carboxy-2-((dioxo-5,6-formylmethyl-4-tetrahydro-1,4,5,6-triazine-1,2,4-yl-3)-thio-2-vinyl)-33-oxo-8-thia-5-aza-1-bicyclo(4.2.0)-octene-2-isomer syn, form E and their preparation
03/13/1984US4436903 Deamination with borohydride compound
03/06/1984CA1163273A2 Substituted heterocyclic phenoxyamines, preparation process and application as topical anesthetics
02/1984
02/22/1984EP0101170A1 Process for the manufacture of sodium cefoperazone
02/21/1984US4433141 7-((2-tritylaminothiazol-4-yl)-2-(2-tert-butoxycarbonylpropyl-2 -oxyimino)acetamide)-3-(1-pyridiniummethyl)ceph-3-em-4-carboxylate
02/14/1984US4431804 Thiazolylacetamido compounds
02/07/1984CA1161836A1 Cephem derivatives and processes for their manufacture
02/07/1984CA1161657A1 N-substituted alanine herbicidal composition
01/1984
01/31/1984CA1161429A1 2-(2-aminothiazol-4-yl)-n-(imidazolidin-2-on-1-yl)-2- imino-acetylaminocephalosporanic acids in pure syn- form, a process for their production and syn-acid used in such a process
01/25/1984EP0099297A1 Cephalosporin derivatives, process for their preparation and antibiotic medicaments containing them
01/25/1984EP0099031A1 Trans-3-(4'-tert.-butylcyclohexyl-1')-2-methyl-1-dialkyl amino propanes, process for their preparation and their use as medicines
01/24/1984US4427675 Bactericides
01/18/1984EP0098291A1 Purification of tetrahydrodibenzo(b,d)pyrans from crude synthetic mixtures
01/10/1984CA1160223A1 Preparation of n-(alkylaminoalkyl) acrylamides
12/1983
12/28/1983EP0097127A2 Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
12/28/1983EP0096720A1 Process for the preparation of B-[(2-methylpropoxy)-methyl]-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine.
12/21/1983EP0096157A2 Substituted acyl derivatives of 1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid
12/20/1983CA1159064A1 Isocyanuric acid derivatives, method of preparation, therapeutic compositions with a cytostatic action and therapeutic method
12/06/1983US4419346 Method and composition to inhibit the growth of Streptococcus mutans by the use of saccharin/fluoride combination
11/1983
11/29/1983CA1157861A2 Octahydro-1h-benzo[4,5]furo[3,2- e]isoquinoline analgesic and narcotic antagonistic compounds
11/24/1983WO1983004023A1 Dihydropyridine derivatives
11/23/1983EP0094911A2 Preparation of pyrrolo-(3,4-c) pyrroles
11/22/1983CA1157477A1 Imidazole hydrazone derivatives
11/16/1983EP0094102A2 1-(1-Cyclohexanyl-methyl) pyrrolidine derivatives, and process for their preparation
11/15/1983CA1156851A1 Herbicidal combinations
11/09/1983EP0093548A2 Cephalosporin derivatives
11/09/1983EP0093376A2 1-Sulfo-2-azetidinone derivatives, their production and use
11/09/1983EP0093338A1 Method for the preparation of cyanohydrine-carboxylic-acid esters
11/08/1983CA1156657A1 Process for the preparation of pharmacologically active carbostyril derivatives
11/08/1983CA1156656A1 Process for the preparation of pyrimidyl-chinazolines
10/1983
10/25/1983US4411897 Crystalline salts
10/25/1983CA1155835A1 Process for preparing cephalosporin derivatives
10/04/1983CA1154778A1 Process for the production of 2-aryl-2h- benzotriazoles
10/04/1983CA1154777A1 Process for the production of 2-aryl-2h- benzotriazoles
09/1983
09/27/1983US4406899 Cephalosporins
09/27/1983CA1154433A1 Cephalosporins, processes for their production and medicaments containing them
09/20/1983US4405782 Salt formation with bicyclic amidine
09/20/1983CA1154023A1 Process for preparing imidazole derivative
09/20/1983CA1154019A1 4-¬3-(1,2,3,4-tetrahydro-2-isoquinolyl)-2- hydroxypropyl|-.delta..sup.2-1,2,4-oxadiazolin-5-one compounds
09/06/1983CA1153382A1 Process for the preparation of 2-(2-thenoylthio)- propionylglycine
08/1983
08/31/1983EP0087148A1 1-Hydroxyethyl-azol derivatives, process for their preparation and their use as plant growth regulators and fungicides
08/30/1983US4401668 Bactericides
08/30/1983US4401667 Cephalosporins
08/23/1983US4400503 Formation of hydrochloride salt
08/16/1983US4399132 Bactericides
08/16/1983US4399131 Cephem derivatives
08/09/1983CA1151641A1 Cephalosporin esters and ethers
08/02/1983US4396620 Cephalosporin quinolinium betaines
08/02/1983US4396619 Cephalosporin betaines
08/02/1983CA1151150A1 Cephalosporins
07/1983
07/19/1983CA1150263A1 Octahydro-1h-benzo ¬4,5| furo ¬3,2-e| isoquinoline analgesic and narcotic antagonistic compounds
07/19/1983CA1150250A1 Hydantoin derivatives
07/19/1983CA1150242A1 ACETOXYMETHYL PENAM COMPOUNDS AS .beta.-LACTAMASE INHIBITORS
07/19/1983CA1150240A1 Process for 3-exomethylenecepham sulfoxides
07/12/1983US4393205 Antibiotics
07/12/1983US4393060 Anticancer
07/07/1983WO1983002275A1 Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
07/07/1983WO1983002274A1 Synthesis of 1-(3-isobutoxy-2-(phenylbenzyl)-amino)-propyl-pyrrolidino hydrochloride
07/05/1983CA1149391A1 Process for the preparation of derivatives of clavulanic acid
06/1983
06/29/1983EP0082666A1 Bis-hydroxymethyl carbonate bridged antibacterial agents
06/14/1983US4388314 Heteromonocyclic and heterobicyclic derivatives of unsaturated 7-acylamido-3-cephem-4-carboxylic acid
06/09/1983WO1983001950A1 1-piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
06/08/1983EP0080992A2 1-Piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them
06/08/1983EP0080944A1 Cephalosporin derivatives substituted in position 3 with a thiomethylheterocyclic group, process for their preparation and pharmaceutical compositions containing them
06/08/1983EP0080592A1 A novel vasodilator compound, process for the preparation thereof and pharmaceutical compositions thereform
06/07/1983CA1147723A1 Cephalosporin derivatives, their production and use
06/01/1983EP0080115A2 Hexahydronaphth(1,2-b)-1,4-oxazines, process for their preparation and pharmaceutical formulation containing them
05/1983
05/31/1983CA1147340A1 Fungicidal 3-(n-acyl-n-arylamino)- and 3- (n-thionoacyl-n-arylamino)-gamma- butyrolactones and gamma-thiobutyrolactones
05/31/1983CA1147322A1 Process for 3-iodomethyl cephalosporins
05/24/1983US4385178 Process for producing 7-(substituted)amino-3-substituted thiomethyl cephem carboxylic acids
05/24/1983US4385054 1-Acetoxyethyl-3-(2-chloroethylcarbamoyloxymethyl)-7-[2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylate
05/24/1983US4385047 Antiasthmatics
05/17/1983CA1146543A1 Cefadroxil salts with amino acids
05/17/1983CA1146541A1 N-carboxy cefadroxil sodium salt
05/17/1983CA1146540A1 CRYSTALLINE HYDROCHLORIDE AND CRYSTALLINE HYDROBROMIDE OF 7.beta.¬2-(2-AMINO-4-THIAZOLYL) -2-METHOXYIMINOACETAMIDO|-3-CEPHEM-4-CARBOXYLIC ACID PIVALOYLOXYMETHYL ESTER
05/11/1983EP0078671A2 Novel cephalosporin salt and its use in a purification process
05/11/1983EP0078532A2 Crystalline salts of cephodizime, and process for their preparation
05/10/1983CA1146165A1 Process for the manufacture of acyl derivatives
05/03/1983CA1145758A1 2,3-dihydro-2-benzofurancarboxamide derivatives
05/03/1983CA1145753A1 Method for the racemization of an optically active tetrahydroisoquinoline derivative
05/03/1983CA1145744A1 3-thiovinyl cephalosporins, preparation thereof and compositions containing them
04/1983
04/26/1983US4381399 Purification of tetrahydrodibenzo[b,d]pyrans from crude synthetic mixtures
04/19/1983US4380630 N-Carboxy cefadroxil sodium salt
04/19/1983CA1144919A1 3-vinyl cephalosporins derivatives and preparation thereof
04/05/1983US4379161 Novel substituted heterocyclic phenoxyamines, the method of preparation thereof and the use thereof as local anaesthetics
04/05/1983CA1144162A1 Compound with a psychostimulant and antidepressive activity process for its preparation and related pharmaceutical compositions
04/05/1983CA1144156A1 Cephalosporin antibiotics
03/1983
03/29/1983CA1143738A1 Substituted 2-phenylamino-imidazolines-(2), the acid addition salts thereof, pharmaceuticals containing same and processes for production thereof
03/15/1983CA1142919A1 Cephalosporin antibiotic
03/01/1983US4375397 Process for preparing 3-methylene cephalosporins
03/01/1983CA1142173A1 Crystalline 3-hydroxycephalosporin solvates
02/1983
02/23/1983EP0072710A1 Carbapenem derivatives, their preparation and compositions containing them
02/23/1983EP0072580A2 1-Hydroxyethyl-azole derivatives, process for their preparation and their use as plant growth regulators and fungicides